Skip to main content
TipRanks
Go Ultimate75% OFF

Axsome Therapeutics (AXSM) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
SolriamfetolAdhdPhase IIIEnrolling By InvitationAn Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHDAug 14, 2026―
Bupropion, Axs-05Smoking CessationPhase IIIRecruitingStudying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)Aug 11, 2026
Solriamfetol Dose A, Solriamfetol Dose BAdhdPhase IIIRecruitingForward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)Jul 16, 2026―
Solriamfetol Dose A, Solriamfetol Dose BAdhdPhase IIIRecruitingForward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)Jul 16, 2026―
Axs-14FibromyalgiaPhase IIIEnrolling By InvitationOpen-Label Safety Study of AXS-14 in Subjects With FibromyalgiaJun 04, 2026
Solriamfetol 150 MgMajor Depressive Disorder With Excessive Daytime Sleepiness SymptomsPhase IIIRecruitingClinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolMar 16, 2026
Axs-14FibromyalgiaPhase IIIRecruitingFibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research DesignFeb 04, 2026
Solriamfetol 75Mg, 150 Mg, Or 300 MgBinge-Eating DisorderPhase IIIEnrolling By InvitationA Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderMar 14, 2025
Axs-05Alzheimer Disease, Agitation In Patients With Dementia Of The Alzheimer's Type, Agitation, PsychomotorPhase IIITerminatedAn Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyDec 12, 2024―
Solriamfetol 150 Mg, Solriamfetol 300 MgExcessive Sleepiness, Shift-Work DisorderPhase IIIRecruitingStudying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)Aug 21, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Axsome Therapeutics Inc. (MX:AXSM) have in its pipeline
Axsome Therapeutics MX:AXSM is currently developing the following drugs: Solriamfetol, Bupropion, Axs-05, Solriamfetol Dose A, Solriamfetol Dose B, Axs-14, Solriamfetol 150 Mg, Solriamfetol 75Mg, 150 Mg, Or 300 Mg, Axs-05, Solriamfetol 150 Mg, Solriamfetol 300 Mg, Solriamfetol 300 Mg, Axs-05, Bupropion, Axs-07, Axs-12, Meloxicam, Axs-07, Rizatriptan. These drug candidates are in various stages of clinical development as the company works toward FDA approval.